Literature DB >> 7488494

Anaesthetic management of acute puerperal uterine inversion.

E Abouleish1, V Ali, B Joumaa, M Lopez, D Gupta.   

Abstract

We identified 18 cases of acute puerperal uterine inversion after vaginal delivery out of 65,581 deliveries in two university-affiliated hospitals (an incidence of 1:3643). In all cases manual repositioning of the uterus without tocolysis was attempted. In four cases this was successful. Of the 14 patients requiring tocolysis, a single dose of terbutaline 0.25 mg i.v. was tried in eight and was successful in five cases (success rate of 63%), while in three patients general anaesthesia was required. In six other patients, general anaesthesia was chosen as the initial management. There was no associated maternal mortality or morbidity with the exception of one case of acute postpartum endometritis. We suggest that when tocolysis is required, terbutaline should be used first because of its rapid onset of action, short duration, simplicity, availability in the labour suite and familiarity to the obstetrician, and general anaesthesia, with its inherent dangers, if possible, should be avoided.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488494     DOI: 10.1093/bja/75.4.486

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  Uterine Inversion Secondary to a Large Prolapsed Leiomyoma: Diagnostic and Management Challenges.

Authors:  Anastasia Martin; Anastasios Tranoulis; Ahmad Sayasneh
Journal:  Cureus       Date:  2020-03-03

2.  Cardiac arrest following acute puerperal uterine inversion.

Authors:  Deb Sanjay Nag; Mamta Rath Datta; Devi Prasad Samaddar; Binita Panigrahi
Journal:  BMJ Case Rep       Date:  2015-02-18

3.  Management of Nonpuerperal Uterine Inversion Using a Combined Vaginal and Abdominal Approach.

Authors:  Ferid A Abubeker; Mulugeta Misgina; Ahmed Ebabu; Eyerusalem Fekade; Biruck Gashawbeza
Journal:  Case Rep Obstet Gynecol       Date:  2020-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.